about
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysisApolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.Measuring change in activities of daily living in nursing home residents with moderate to severe cognitive impairmentThe independent contribution of executive functions to health related quality of life in older women.Alzheimer's disease in the United Kingdom: developing patient and carer support strategies to encourage care in the community.Relation between severity of Alzheimer's disease and costs of caringCauses of Alzheimer's diseaseLong-term care eligibility criteria for people with Alzheimer's diseaseAn economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairmentNational estimates of the quantity and cost of informal caregiving for the elderly with dementia.Caregiver perceptions regarding the measurement of level and quality of care in Alzheimer's disease.Direct costs of dementia in nursing homes.Caregiver- and patient-directed interventions for dementia: an evidence-based analysis.Methodological considerations in cost of illness studies on Alzheimer disease.A longitudinal study looking at and beyond care recipient health as a predictor of long term care home admission.SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment.
P2860
Q24805169-753370E2-8940-4769-8EF4-7ADFDB5357C1Q30969340-0994DE2E-90BD-4477-BAE7-586F2A0A34FCQ33238508-75EBDE4A-F755-4074-BE8C-CF36E6EA348AQ33548532-97B0797B-46CD-4F2D-AEF8-E419971FB3C1Q33578920-292FF509-DC01-4E0E-8313-7AD9BEADEC21Q34029549-699B20E0-CB02-41ED-8D38-985134AF4CDAQ34037204-3D0DAEE9-D111-498D-AB95-AB853273EBA7Q34326803-D23297BB-C2A7-414D-8DEF-5B3155AA1B51Q34729983-C2E4CC95-B79E-460A-BF2A-359D7637C5E7Q34744409-8903E053-31FD-426B-A824-D724A0BC6E3AQ35821004-DEA3E690-27AC-4573-A84E-44ADDF68D0ADQ35895147-20C6D6B7-74A7-4AAB-AF7A-0E45C7187691Q36039976-A265BDAE-BB59-44C1-B9E0-614602C73495Q36585433-2D719271-92F7-4C05-B57D-8590CD9AA112Q45347875-03635188-172C-4EE5-88AE-AE97099B336CQ52585122-BF53D0A4-4EBB-40EC-B9DE-362DE23BB3A5
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Net economic costs of dementia in Canada.
@ast
Net economic costs of dementia in Canada.
@en
Net economic costs of dementia in Canada.
@nl
type
label
Net economic costs of dementia in Canada.
@ast
Net economic costs of dementia in Canada.
@en
Net economic costs of dementia in Canada.
@nl
prefLabel
Net economic costs of dementia in Canada.
@ast
Net economic costs of dementia in Canada.
@en
Net economic costs of dementia in Canada.
@nl
P2860
P1476
Net economic costs of dementia in Canada
@en
P2093
P2860
P304
P407
P577
1994-11-01T00:00:00Z